HAE
Haemonetics Corp
Price:  
87.47 
USD
Volume:  
273,618.00
United States | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HAE EV/EBITDA

-0.1%
Upside

As of 2024-12-05, the EV/EBITDA ratio of Haemonetics Corp (HAE) is 16.38. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. HAE's latest enterprise value is 5,318.42 mil USD. HAE's TTM EBITDA according to its financial statements is 324.61 mil USD. Dividing these 2 quantities gives us the above HAE EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 10.7x - 17.5x 13.8x
Forward P/E multiples 16.7x - 24.4x 21.0x
Fair Price 50.47 - 123.20 87.38
Upside -42.3% - 40.9% -0.1%
87.47 USD
Stock Price
87.38 USD
Fair Price

HAE EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-11-26 16.70
2024-11-25 16.54
2024-11-22 16.09
2024-11-21 16.07
2024-11-20 15.99
2024-11-19 15.98
2024-11-18 16.49
2024-11-15 16.65
2024-11-14 16.89
2024-11-13 17.05
2024-11-12 17.30
2024-11-11 16.99
2024-11-08 16.38
2024-11-07 16.24
2024-11-06 14.94
2024-11-05 14.45
2024-11-04 14.23
2024-11-01 13.91
2024-10-31 13.86
2024-10-30 13.99
2024-10-29 14.16
2024-10-28 14.57
2024-10-25 14.54
2024-10-24 14.58
2024-10-23 14.19
2024-10-22 14.37
2024-10-21 14.43
2024-10-18 14.63
2024-10-17 14.60
2024-10-16 14.54
2024-10-15 14.48
2024-10-14 14.50
2024-10-11 14.45
2024-10-10 14.37
2024-10-09 14.63
2024-10-08 14.71
2024-10-07 14.79
2024-10-04 14.90
2024-10-03 14.93
2024-10-02 15.12
2024-10-01 15.07
2024-09-30 15.29
2024-09-27 15.20
2024-09-26 14.69
2024-09-25 14.47
2024-09-24 14.53
2024-09-23 14.67
2024-09-20 14.43
2024-09-19 14.47
2024-09-18 14.55